European Medicines Agency validates Nuvation Bio’s taletrectinib MAA for advanced ROS1-positive non-small cell lung cancer
https://finviz.com/quote.ashx?t=NUVB&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.